Home / Stocks / CNC

Centene (CNC, Managed Health Care) Stock Valuation & Fair Value Fairly valued

Centene (CNC, Managed Health Care) trades at a blended P/E of 16.8, about 2% below its historical normal valuation, with a forward growth estimate of 23.7% and a PEG of 0.71. Analysts' one-year estimates have been hit 64% of the time.

No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation, forecast return and analyst accuracy only. Ratings that cite business quality require one.

DATA AS OF 2026-08-28
Blended P/E
16.8
Normal P/E
17.2
PEG
0.71
Fwd growth
23.7%
Div yield
0.0%
RSI (14)
51.1
Neutral

The Street vs SeerForecast

Wall Street's mean price target for CNC is $71.67 across 18 analysts, 10.7% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: fairly valued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from trading above fair value (2026-06-03) to fairly valued (2026-08-28).

Price and rating by weekClose moved +9.2 percent from 2026-06-03 to 2026-08-24, with 3 rating changes over 23 recorded weeks.2026-06-03: Trading above fair value, close 59.55 (recalculated)2026-06-10: Trading above fair value, close 65.34 (recalculated)2026-06-14: Trading above fair value, close 65.19 (recalculated)2026-06-16: Trading above fair value, close 61.39 (recalculated)2026-06-21: Trading above fair value, close 61.02 (recalculated)2026-07-02: Significantly overvalued, close 67.86 (recalculated)2026-07-06: Significantly overvalued, close 66.05 (recalculated)2026-07-09: Significantly overvalued, close 67.60 (recalculated)2026-07-12: Significantly overvalued, close 67.35 (recalculated)2026-07-13: Significantly overvalued, close 68.29 (recalculated)2026-07-14: Significantly overvalued, close 68.72 (recalculated)2026-07-20: Trading above fair value, close 65.84 (recalculated)2026-07-22: Trading above fair value, close 65.89 (recalculated)2026-07-25: Trading above fair value, close 63.41 (recalculated)2026-07-27: Trading above fair value, close 64.08 (recalculated)2026-07-31: Fairly valued, close 62.22 (recalculated)2026-08-03: Fairly valued, close 62.222026-08-07: Fairly valued, close 65.77 (recalculated)2026-08-10: Fairly valued, close 65.772026-08-14: Fairly valued, close 67.47 (recalculated)2026-08-17: Fairly valued, close 67.472026-08-21: Fairly valued, close 65.02 (recalculated)2026-08-24: Fairly valued, close 65.0260652026-06-032026-08-24
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 22.3+30%Trading above fair value
2026-06-10P/E 23.4+36%Trading above fair value
2026-06-14P/E 23.4+36%Trading above fair value
2026-06-16P/E 23.4+36%Trading above fair value
2026-06-21P/E 23.4+36%Trading above fair value
2026-07-02P/E 24.7+44%Significantly overvalued
2026-07-06P/E 24.5+43%Significantly overvalued
2026-07-09P/E 24.5+43%Significantly overvalued
2026-07-12P/E 24.0+40%Significantly overvalued
2026-07-13P/E 24.0+40%Significantly overvalued
2026-07-14P/E 24.0+40%Significantly overvalued
2026-07-20P/E 23.5+37%Trading above fair value
2026-07-22P/E 23.5+37%Trading above fair value
2026-07-25P/E 22.2+29%Trading above fair value
2026-07-27P/E 22.2+29%Trading above fair value
2026-07-31P/E 16.6-3%Fairly valued
2026-08-03P/E 16.9-1%Fairly valued
2026-08-07P/E 17.2+0%Fairly valued
2026-08-10P/E 17.6+2%Fairly valued
2026-08-14P/E 17.4+1%Fairly valued
2026-08-17P/E 17.8+3%Fairly valued
2026-08-21P/E 16.7-3%Fairly valued
2026-08-24P/E 16.9-2%Fairly valued
2026-08-27P/E 16.9-2%Fairly valued
2026-08-28P/E 16.8-2%Fairly valued ← now

Frequently asked questions

Is Centene stock overvalued?

At a blended P/E of 16.8 versus its historical normal P/E of 17.2, Centene trades about 2% below its typical valuation, with a PEG of 0.71 on 23.7% forward growth. tickerseer currently rates it fairly valued.

What is Centene's fair value and PEG?

Centene trades at a blended P/E of 16.8 against a historical normal P/E of 17.2, a PEG of 0.71, and a forward growth estimate of 23.7%.

Has tickerseer's rating of Centene changed?

tickerseer's rating moved from trading above fair value (2026-06-03) to fairly valued (2026-08-28).

What is the analyst price target for Centene?

The mean Wall Street price target for Centene is $71.67 across 18 analysts, 10.7% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Managed Health Care. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track CNC free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.